Stallergenes Czech Republic

Last updated: 13.02.2014

Address: Belgicka 20 – 120 00 Praha 2 ,Czech Republic

Tel: +420 222 515 342 

Web: http://www.stallergenes.cz/

Company description

Stallergenes is a European biopharmaceutical company specialised in the treatment by allergen immunotherapy of allergy related respiratory diseases, such as severe rhinoconjunctivitis and rhinitis, as well as allergic asthma. A pioneer and a leader in immunotherapy treatments by sublingual administration, Stallergenes dedicates nearly 20% (gross) of its sales to its Research and Development activities, which are primarily directed at developing a new therapeutic range: sublingual immunotherapy tablets. In 2011, the company had sales of € 235 million and more than 500,000 patients were treated with Stallergenes products.

Products and services

Sublingual immunotherapy tablets
NPPs
Diagnosis products

Interviews

Related

We use cookies to ensure that we give you the best experience on our site. For more info click here